Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Syk activation of phosphatidylinositol 3-kinase/Akt prevents HtrA2-dependent loss of X-linked inhibitor of apoptosis protein (XIAP) to promote survival of Epstein-Barr virus+ (EBV+) B cell lymphomas.
Hatton O, Phillips LK, Vaysberg M, Hurwich J, Krams SM, Martinez OM.
J Biol Chem. 2011 Oct 28;286(43):37368-78. Epub 2011 Sep 9.
Related citations
Demonstration that drug-targeted down-regulation of MYC in non-Hodgkins lymphoma is directly mediated through the promoter G-quadruplex.
Brown RV, Danford FL, Gokhale V, Hurley LH, Brooks TA.
J Biol Chem. 2011 Nov 25;286(47):41018-27. Epub 2011 Sep 28.
The nucleophosmin-anaplastic lymphoma kinase oncogene interacts, activates, and uses the kinase PIKfyve to increase invasiveness.
Dupuis-Coronas S, Lagarrigue F, Ramel D, Chicanne G, Saland E, Gaits-Iacovoni F, Payrastre B, Tronchère H.
J Biol Chem. 2011 Sep 16;286(37):32105-14. Epub 2011 Jul 7.
The E3 ubiquitin ligase mind bomb-2 (MIB2) protein controls B-cell CLL/lymphoma 10 (BCL10)-dependent NF-κB activation.
Stempin CC, Chi L, Giraldo-Vela JP, High AA, Häcker H, Redecke V.
J Biol Chem. 2011 Oct 28;286(43):37147-57. Epub 2011 Sep 6.
The Casitas B lineage lymphoma (Cbl) mutant G306E enhances osteogenic differentiation in human mesenchymal stromal cells in part by decreased Cbl-mediated platelet-derived growth factor receptor alpha and fibroblast growth factor receptor 2 ubiquitination.
Sévère N, Miraoui H, Marie PJ.
J Biol Chem. 2011 Jul 8;286(27):24443-50. Epub 2011 May 19.
Angiopoietin-2, an angiogenic regulator, promotes initial growth and survival of breast cancer metastases to the lung through the integrin-linked kinase (ILK)-AKT-B cell lymphoma 2 (Bcl-2) pathway.
Imanishi Y, Hu B, Xiao G, Yao X, Cheng SY.
J Biol Chem. 2011 Aug 19;286(33):29249-60. Epub 2011 Jun 16.
Novel mechanism of anti-apoptotic function of 78-kDa glucose-regulated protein (GRP78): endocrine resistance factor in breast cancer, through release of B-cell lymphoma 2 (BCL-2) from BCL-2-interacting killer (BIK).
Zhou H, Zhang Y, Fu Y, Chan L, Lee AS.
J Biol Chem. 2011 Jul 22;286(29):25687-96. Epub 2011 May 26.
Reactive oxygen species regulate nucleostemin oligomerization and protein degradation.
Huang M, Whang P, Chodaparambil JV, Pollyea DA, Kusler B, Xu L, Felsher DW, Mitchell BS.
J Biol Chem. 2011 Apr 1;286(13):11035-46. Epub 2011 Jan 17.
Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1).
Arcipowski KM, Stunz LL, Graham JP, Kraus ZJ, Vanden Bush TJ, Bishop GA.
J Biol Chem. 2011 Mar 25;286(12):9948-55. Epub 2011 Jan 24.
Decreased diacylglycerol metabolism enhances ERK activation and augments CD8+ T cell functional responses.
Riese MJ, Grewal J, Das J, Zou T, Patil V, Chakraborty AK, Koretzky GA.
J Biol Chem. 2011 Feb 18;286(7):5254-65. Epub 2010 Dec 7.
SKP2 oncogene is a direct MYC target gene and MYC down-regulates p27(KIP1) through SKP2 in human leukemia cells.
Bretones G, Acosta JC, Caraballo JM, Ferrándiz N, Gómez-Casares MT, Albajar M, Blanco R, Ruiz P, Hung WC, Albero MP, Perez-Roger I, León J.
J Biol Chem. 2011 Mar 18;286(11):9815-25. Epub 2011 Jan 18.
NF-kappaB down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway.
Thompson RC, Herscovitch M, Zhao I, Ford TJ, Gilmore TD.
J Biol Chem. 2011 Jan 21;286(3):1675-82. Epub 2010 Oct 14.
MicroRNA (miRNA)-mediated interaction between leukemia/lymphoma-related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis.
Verduci L, Simili M, Rizzo M, Mercatanti A, Evangelista M, Mariani L, Rainaldi G, Pitto L.
J Biol Chem. 2010 Dec 10;285(50):39551-63. Epub 2010 Oct 4.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on